For GSK, It’s Last Call For a Drug Based on Resveratrol


Published On: December 2nd, 2010

GSK says it won’t study SRT501 further but is still waiting for data from other, completed trials.

More: 
For GSK, It’s Last Call For a Drug Based on Resveratrol



Loading...


Comments are closed.